
Virginie MILLET
About
Virginie Millet, ingénieure en biologie cellulaire et moléculaire, a rejoint l’équipe d’Achille Broggi “Immunité innée au niveau des muqueuses” en 2022, où elle se spécialise dans l’étude des modèles d’organoïdes intestinaux.
Elle a auparavant consacré vingt années de recherche, aux côtés du Pr Philippe Naquet, à l’exploration des molécules Vanin et leur implication dans les maladies inflammatoires et le cancer.
Projects
Project
2025
Type IlI Interferons, master regulator of mucosal homeostasis. – INTERMUCOSAL
Project: INTERMUCOSAL This project explores the role of an immune system molecule called type III interferon (IFN-λ). This […]

Sarah WURBEL

Chloé RIQUIER

Virginie MILLET
Project
2025
MetaNiche (Spatial-SCENITH) Metabolic niches regulate hematopoiesis (MetaNiche, ANR-22-CE15-0015-02).
Bone marrow metabolic niches regulate hematopoiesis (MetaNiche, ANR-22-CE15-0015-02). Duration: 2023–2027 (42 months).Partners & funding amounts: Institut Curie (L. Perié), Institut […]

Rafael J ARGUELLO
Publications
2024
Type III interferons induce pyroptosis in gut epithelial cells and odd mucosal repair.
Cell 2024 Dec; 187(26): 7533-7550.e23.
2023
The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma,
<i>Life Science Alliance</i>, 2023, 6 (12), pp.e202302200. <a target="_blank" href="https://dx.doi.org/10.26508/lsa.202302200">⟨10.26508/lsa.202302200⟩</a>.
2023
The vitamin B5/coenzyme A axis: A target for immunomodulation?,
<i>European Journal of Immunology</i>, 2023, 53 (10), <a target="_blank" href="https://dx.doi.org/10.1002/eji.202350435">⟨10.1002/eji.202350435⟩</a>.
2023
An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity.
Life Sci Alliance 2023 Jun; 6(6): .
2018
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity.
Life Sci Alliance 2018 Aug; 1(4): e201800073.
2013
PPARalpha regulates the production of serum Vanin-1 by liver.
FEBS Lett 2013 Nov; 587(22): 3742-8.
2010
Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Inflamm Bowel Dis 2010 Jan; 16(1): 96-104.
2008
Intercellular MHC transfer between thymic epithelial and dendritic cells.,
Eur J Immunol 2008 May; 38(5): 1257-63.
2006
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity.
<i>Journal of Experimental Medicine</i>, 2006, 203 (13), pp.2817-27. <a target="_blank" href="https://dx.doi.org/10.1084/jem.20061640">⟨10.1084/jem.20061640⟩</a>.
2004
Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells.,
Stem Cells 2004 ; 22(1): 74-85.
2002
Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis.,
Hum Gene Ther 2002 Dec; 13(18): 2161-72.
2002
Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis.,
Hum Gene Ther 2002 Jul; 13(10): 1179-88.